Patent Number: 8,877,742

Title: Compounds

Abstract: The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase enzymes.

Inventors: Chen; Deborah W. (Singapore, SG), Duncan; Sarah (Singapore, SG), King; Nigel Paul (Singapore, SG), Lee; Kiew Ching (Singapore, SG), Mak; Sing Yeung (Singapore, SG), Rivers; Dean Andrew (Singapore, SG)

Assignee: GlaxoSmithKline Intellectual Property Limited

International Classification: C07D 471/04 (20060101); C07D 498/04 (20060101)

Expiration Date: 2019-11-04 0:00:00